img

Global PD-L1 Biomarker Testing Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global PD-L1 Biomarker Testing Market Research Report 2024

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
According to MRAResearch’s new survey, global PD-L1 Biomarker Testing market is projected to reach US$ 14870 million in 2033, increasing from US$ 1470.5 million in 2022, with the CAGR of 38.7% during the period of 2023 to 2033.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global PD-L1 Biomarker Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Agilent Technologies
Roche
Segment by Type
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other

Segment by Application


Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The PD-L1 Biomarker Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 PD-L1 (22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1 (SP142)
1.2.5 PD-L1 (SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2018-2033)
2.2 PD-L1 Biomarker Testing Growth Trends by Region
2.2.1 Global PD-L1 Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2018-2023)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2024-2033)
2.3 PD-L1 Biomarker Testing Market Dynamics
2.3.1 PD-L1 Biomarker Testing Industry Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 Biomarker Testing Players by Revenue
3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2018-2023)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2018-2023)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2022
3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served
3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service
3.7 Date of Enter into PD-L1 Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2018-2023)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2024-2033)
5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2018-2023)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2018-2033)
6.2 North America PD-L1 Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America PD-L1 Biomarker Testing Market Size by Country (2018-2023)
6.4 North America PD-L1 Biomarker Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2018-2033)
7.2 Europe PD-L1 Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe PD-L1 Biomarker Testing Market Size by Country (2018-2023)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2018-2033)
8.2 Asia-Pacific PD-L1 Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PD-L1 Biomarker Testing Market Size (2018-2033)
9.2 Latin America PD-L1 Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America PD-L1 Biomarker Testing Market Size by Country (2018-2023)
9.4 Latin America PD-L1 Biomarker Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2018-2033)
10.2 Middle East & Africa PD-L1 Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 Biomarker Testing Introduction
11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2018-2023)
11.2.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of PD-L1 (22C3)
Table 3. Key Players of PD-L1(28-8)
Table 4. Key Players of PD-L1 (SP142)
Table 5. Key Players of PD-L1 (SP263)
Table 6. Key Players of Other
Table 7. Global PD-L1 Biomarker Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2018-2023)
Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2024-2033)
Table 13. PD-L1 Biomarker Testing Market Trends
Table 14. PD-L1 Biomarker Testing Market Drivers
Table 15. PD-L1 Biomarker Testing Market Challenges
Table 16. PD-L1 Biomarker Testing Market Restraints
Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global PD-L1 Biomarker Testing Market Share by Players (2018-2023)
Table 19. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2022)
Table 20. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players PD-L1 Biomarker Testing Product Solution and Service
Table 24. Date of Enter into PD-L1 Biomarker Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2018-2023)
Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2024-2033)
Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2018-2023)
Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2024-2033)
Table 34. North America PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific PD-L1 Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 49. Agilent Technologies Company Detail
Table 50. Agilent Technologies Business Overview
Table 51. Agilent Technologies PD-L1 Biomarker Testing Product
Table 52. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2018-2023) & (US$ Million)
Table 53. Agilent Technologies Recent Development
Table 54. Roche Company Detail
Table 55. Roche Business Overview
Table 56. Roche PD-L1 Biomarker Testing Product
Table 57. Roche Revenue in PD-L1 Biomarker Testing Business (2018-2023) & (US$ Million)
Table 58. Roche Recent Development
Table 59. Research Programs/Design for This Report
Table 60. Key Data Information from Secondary Sources
Table 61. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 Biomarker Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global PD-L1 Biomarker Testing Market Share by Type: 2022 VS 2033
Figure 3. PD-L1 (22C3) Features
Figure 4. PD-L1(28-8) Features
Figure 5. PD-L1 (SP142) Features
Figure 6. PD-L1 (SP263) Features
Figure 7. Other Features
Figure 8. Global PD-L1 Biomarker Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global PD-L1 Biomarker Testing Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Diagnostic Center Case Studies
Figure 12. Others Case Studies
Figure 13. PD-L1 Biomarker Testing Report Years Considered
Figure 14. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global PD-L1 Biomarker Testing Market Share by Region: 2022 VS 2033
Figure 17. Global PD-L1 Biomarker Testing Market Share by Players in 2022
Figure 18. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2022
Figure 20. North America PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America PD-L1 Biomarker Testing Market Share by Country (2018-2033)
Figure 22. United States PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe PD-L1 Biomarker Testing Market Share by Country (2018-2033)
Figure 26. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific PD-L1 Biomarker Testing Market Share by Region (2018-2033)
Figure 34. China PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America PD-L1 Biomarker Testing Market Share by Country (2018-2033)
Figure 42. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa PD-L1 Biomarker Testing Market Share by Country (2018-2033)
Figure 46. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries